Literature DB >> 22714720

Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women.

Natalia Palacios1, Xiang Gao, Eilis O'Reilly, Michael Schwarzschild, Marjorie L McCullough, Tinisha Mayo, Susan M Gapstur, Alberto A Ascherio.   

Abstract

Addictive behaviors, such as cigarette smoking and coffee drinking, have been associated with a reduced risk of Parkinson's disease (PD). Whether alcohol consumption is also associated with PD risk is less certain. We prospectively followed 132,403 participants in the Cancer Prevention Study II Nutrition Cohort from 1992 to 2005. Alcohol intake was assessed at baseline. Incident cases of PD (n = 605; 389 male and 216 female) were confirmed by treating physicians and medical record review. Relative risks (RRs) were estimated using proportional hazards models, adjusting for age, smoking, and other risk factors. Alcohol consumption was not significantly associated with PD risk. After adjustment for age, smoking, and other risk factors, the RR comparing men consuming 30 or more grams of alcohol per day (highest category) to nondrinker men was 1.29 (95% confidence interval [CI]: 0.90, 1.86; P trend: 0.40), and the RR comparing women consuming 15 or more grams of alcohol (highest category) per day to nondrinker women was 0.77 (95% CI: 0.41, 1.45; P trend: 0.87). Consumption of beer, wine, or liquor was also not associated with PD risk. The results of this large, prospective study do not support an association between alcohol intake and risk of PD.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22714720      PMCID: PMC3548327          DOI: 10.1002/mds.25050

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  41 in total

1.  Validation of the American Cancer Society Cancer Prevention Study II Nutrition Survey Cohort Food Frequency Questionnaire.

Authors:  E W Flagg; R J Coates; E E Calle; N Potischman; M J Thun
Journal:  Epidemiology       Date:  2000-07       Impact factor: 4.822

2.  Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.

Authors:  K P Castagnoli; S J Steyn; J P Petzer; C J Van der Schyf; N Castagnoli
Journal:  Chem Res Toxicol       Date:  2001-05       Impact factor: 3.739

3.  Risk factors for parkinson's disease: the leisure world cohort study.

Authors:  A Paganini-Hill
Journal:  Neuroepidemiology       Date:  2001-05       Impact factor: 3.282

4.  Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

Authors:  A Ascherio; S M Zhang; M A Hernán; I Kawachi; G A Colditz; F E Speizer; W C Willett
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

5.  Risk factors of Parkinson's disease in Indian patients.

Authors:  M Behari; A K Srivastava; R R Das; R M Pandey
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

6.  Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.

Authors:  A J Hughes; S E Daniel; A J Lees
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

7.  Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study.

Authors:  M D Benedetti; J H Bower; D M Maraganore; S K McDonnell; B J Peterson; J E Ahlskog; D J Schaid; W A Rocca
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

Review 8.  The personality associated with Parkinson's disease.

Authors:  M Menza
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

9.  Cigarette smoking and the incidence of Parkinson's disease in two prospective studies.

Authors:  M A Hernán; S M Zhang; A M Rueda-deCastro; G A Colditz; F E Speizer; A Ascherio
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

10.  Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality.

Authors:  Eilis J O'Reilly; Honglei Chen; Hannah Gardener; Xiang Gao; Michael A Schwarzschild; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2009-01-08       Impact factor: 4.897

View more
  23 in total

1.  Reduced risk of Parkinson's disease associated with lower body mass index and heavy leisure-time physical activity.

Authors:  Katri Sääksjärvi; Paul Knekt; Satu Männistö; Jukka Lyytinen; Tuija Jääskeläinen; Noora Kanerva; Markku Heliövaara
Journal:  Eur J Epidemiol       Date:  2014-03-16       Impact factor: 8.082

2.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

Review 3.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

4.  Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study.

Authors:  Thanh G N Ton; Mary Lou Biggs; Diane Comer; Lesley Curtis; Shu-Ching Hu; Evan L Thacker; Susan Searles Nielsen; Joseph A Delaney; Douglas Landsittel; William T Longstreth; Harvey Checkoway; Samay Jain
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-12-13       Impact factor: 2.890

5.  Lifestyle, family history, and risk of idiopathic Parkinson disease: a large Danish case-control study.

Authors:  Line Kenborg; Christina F Lassen; Beate Ritz; Klaus K Andersen; Jane Christensen; Eva S Schernhammer; Johnni Hansen; Lene Wermuth; Naja H Rod; Jørgen H Olsen
Journal:  Am J Epidemiol       Date:  2015-04-29       Impact factor: 4.897

Review 6.  Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 3: Treatment.

Authors:  S Schlee; L C Bollheimer; T Bertsch; C C Sieber; P Härle
Journal:  Z Gerontol Geriatr       Date:  2017-02-28       Impact factor: 1.281

Review 7.  Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 1: Epidemiology and pathophysiology.

Authors:  S Schlee; L C Bollheimer; T Bertsch; C C Sieber; P Härle
Journal:  Z Gerontol Geriatr       Date:  2017-02-23       Impact factor: 1.281

Review 8.  Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Authors:  Song Li; Jie Dong; Cheng Cheng; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2016-08-11       Impact factor: 3.575

9.  Acetaldehyde and parkinsonism: role of CYP450 2E1.

Authors:  Francesca Vaglini; Cristina Viaggi; Valentina Piro; Carla Pardini; Claudio Gerace; Marco Scarselli; Giovanni Umberto Corsini
Journal:  Front Behav Neurosci       Date:  2013-06-21       Impact factor: 3.558

10.  Alcohol Consumption, Types of Alcohol, and Parkinson's Disease.

Authors:  Rui Liu; Xuguang Guo; Yikyung Park; Jian Wang; Xuemei Huang; Albert Hollenbeck; Aaron Blair; Honglei Chen
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.